Oramed Pharmaceuticals Inc.

ORMP | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.72

+$0.02 (+0.43%)

Sep 22, 2026, 12:30 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Aug 30, 2021	FY 2020 Aug 30, 2020
Cash & Equivalents	45.95M	54.42M	9.06M	40.46M	77.25M	19.3M
Short-Term Investments	79.95M	87.51M	152.99M	115.26M	16.9M	20.6M
Long-Term Investments	93.74M	10.91M	56.37M	2.7M	6.69M	3.93M
Other Long-Term Assets	2.52M	34K	34K	24K	25.04M	20K
Receivables	4.64M	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.74M	1.29M	537K	1.39M	1.2M	611K
Total Current Assets	133.27M	143.22M	162.58M	157.11M	95.34M	40.51M
Property-Plant & Equipment	1.34M	1.11M	1.57M	1.81M	932K	174K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	97.59M	12.06M	57.97M	4.53M	32.66M	4.12M
Total Assets	230.86M	155.28M	220.55M	161.64M	128M	44.63M
Account Payables	443K	789K	551K	2.18M	2.61M	594K
Deferred Revenue	1.35M	n/a	n/a	1.34M	2.7M	2.7M
Short-Term Debt	285K	n/a	51.01M	247K	130K	44K
Other Current Liabilities	2.37M	1.07M	325K	-191K	-1.37M	601K
Total Current Liabilities	19.09M	5.69M	53.21M	5.75M	6.68M	4.54M
Long-Term Debt	n/a	n/a	n/a	647K	403K	31K
Other Long-Term Liabilities	314K	90K	102K	82K	145K	229K
Total Long-Term Liabilities	12.03M	4.25M	4.44M	4.74M	4.8M	7.22M
Total Liabilities	31.12M	9.93M	57.66M	10.49M	11.48M	11.75M
Total Debt	825K	372K	51.62M	894K	533K	75K
Book Value	199.74M	145.35M	162.89M	151.16M	116.52M	32.88M
Book Value Per Share	4.71	3.56	4.02	3.88	4.09	1.60
Common Stock	472K	480K	485K	476K	424K	284K
Retained Earnings	-123.44M	-176.62M	-157.56M	-163.08M	-114.85M	-92.61M
Comprehensive Income	0	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	199.74M	146.27M	163.82M	151.81M	115.77M	32.88M
Total Investments	173.68M	98.42M	209.36M	117.96M	23.59M	24.53M